资讯

Kaizer Chiefs and Sekhukhune United are both eyeing top spot in the Betway Premiership as the two sides meet at the FNB ...
It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for ...
Olympic champions Faith Kipyegon (1 500 metres) and Hamish Kerr (high jump) headline day four of the World Athletics ...
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the best mid-cap stocks with huge upside potential. H.C. Wainwright reaffirmed its Buy rating and $180 price target for Axsome Therapeutics Inc.
The real question is how to re-shore pharmaceutical production while minimizing the costs to patients, economist Tomas J.
Investing.com - H.C. Wainwright has reiterated its Buy rating and $180.00 price target on Axsome Therapeutics (NASDAQ:AXSM), currently trading at $117.14, following a generic challenge to the ...
The Food and Drug Administration signed off on the first-ever weight-loss generic on Thursday, a knockoff of Novo Nordisk'sNVO Saxenda from Teva PharmaceuticalTEVA. Saxenda, the branded name for ...
Green Garden brand mint sold in Canada has been recalled due to generic E. coli. The recalled mint was distributed in Ontario and Quebec.
In today’s competitive convenience and fuel retail landscape, personalization is no longer a nice-to-have—it’s a necessity.